Print

A Pilot Study Investigating the Views of Key Stakeholders on Somatic and Germline Cancer Testing

https://www.facingourrisk.org/research-clinical-trials/study/298/individuals-views-on-somatic-and-germline-testing

Surveys, Registries, Interviews
This is a survey research study enrolling people with a history of cancer, cancer genetic testing, and an inherited mutation or variant of uncertain significance (VUS) in a hereditary cancer gene

Study Contact Information:

Please feel free to contact [email protected] with any questions.


About the Study

The goal of this study is to explore individuals’ views on somatic and germline cancer testing to inform future studies. This is a 10-15 minute web survey research study enrolling people with a history of cancer, cancer genetic testing, and an inherited mutation or variant of uncertain significance (VUS) in a hereditary cancer gene (e.g., APC, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CDK4, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53).

What the Study Involves

This pilot study is a mixed-methods study exploring individuals’ views on somatic and germline cancer testing. The study consists of a web survey which will take about 10-15 minutes to complete. Participants can voluntarily provide their email address to express interest in an optional follow-up interview.

Eligibility

 Participants are eligible to participate in this research study if they:

Process

Please click here to begin.

Lead Researcher

Principal Investigator: Kunal Sanghavi, MBBS, MS, CGC

Senior Program Manager - Genetic Counseling, The Jackson Laboratory for Genomic Medicine
10 Discovery Dr.
Farmington, CT 06032
[email protected]


This Study is Open To:

Participants are eligible to participate in this research study if they:

This Study is Not Open To:

Participants are not eligible if:


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.